Literature DB >> 28399973

Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.

L V Adams1, D Basu2, S W Grande3, S R Craig4, M T Patridge3, N Panth3, V Trump Redd3, M Phalaste5, A Singo5, P Osewe6, A G Mulley7.   

Abstract

SETTING: South African miners suffer the highest tuberculosis (TB) rates in the world. Current efforts to stem the epidemic are insufficient. Historical legacies and persistent disease burden demand innovative approaches to reshape health care delivery to better serve this population.
OBJECTIVE: To characterize social and behavioral health determinants for successful TB care delivery and treatment from the perspective of miners/ex-miners, health care workers and policy makers/managers.
DESIGN: We conducted applied ethnography with 30 miners/ex-miners, 13 family/community members, 14 health care providers, and 47 local policy makers/managers in South Africa.
RESULTS: Miners/ex-miners felt health care delivery systems failed to meet their needs. Many had experienced unnecessary physical and psychological harm due to limited health education about TB, minimal engagement in their own care, lack of trust in providers, and a system that did not value their experience. Stigma and fear associated with TB result in denial of symptoms and delays in care seeking. Health care providers and policy makers/managers felt discouraged by system constraints in providing optimal care.
CONCLUSION: Our findings describe long-term effects of perpetual TB misinformation and stigma resulting from fear and disempowerment among miners and their families/communities. To reduce the TB burden, there is an urgent need to co-design a care delivery system with miners to better meet their needs.

Entities:  

Mesh:

Year:  2017        PMID: 28399973     DOI: 10.5588/ijtld.16.0669

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

Review 1.  Closing gaps in the tuberculosis care cascade: an action-oriented research agenda.

Authors:  Ramnath Subbaraman; Tulip Jhaveri; Ruvandhi R Nathavitharana
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-01-11

2.  Role of Treatment Adherence, Doctor-Patient Trust, and Communication in Predicting Treatment Effects Among Tuberculosis Patients: Difference Between Urban and Rural Areas.

Authors:  Liang Du; Ruiheng Wu; Xu Chen; Jia Xu; Haoqiang Ji; Ling Zhou
Journal:  Patient Prefer Adherence       Date:  2020-11-24       Impact factor: 2.711

3.  Tackling injustices of occupational lung disease acquired in South African mines: recent developments and ongoing challenges.

Authors:  Barry Kistnasamy; Annalee Yassi; Jessica Yu; Samuel J Spiegel; Andre Fourie; Stephen Barker; Jerry M Spiegel
Journal:  Global Health       Date:  2018-06-28       Impact factor: 4.185

4.  Perceived Stigma and Associated Factors among Patient with Tuberculosis, Wolaita Sodo, Ethiopia: Cross-Sectional Study.

Authors:  Bereket Duko; Asres Bedaso; Getinet Ayano; Zegeye Yohannis
Journal:  Tuberc Res Treat       Date:  2019-05-02

5.  Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis.

Authors:  Alvin Kuo Jing Teo; Shweta R Singh; Kiesha Prem; Li Yang Hsu; Siyan Yi
Journal:  Respir Res       Date:  2021-09-23

6.  Zambia Assessment of Tuberculosis (TB) and HIV in the Mines (ZATHIM): implications for programs and policies.

Authors:  Laura Jean Podewils; Elizabeth F Long; Tyler J Fuller; David Mwakazanga; Kelvin Kapungu; Mathias Tembo; Sydney Mwanza; Kathryn G Curran; Jonathan P Smith; James L Tobias; Webster Kasongo
Journal:  BMC Public Health       Date:  2022-04-20       Impact factor: 4.135

7.  Perceptions about tuberculosis and perceived tuberculosis-related stigma and associated factors among the mining community in Eswatini.

Authors:  Charles Maibvise; Mduduzi Shongwe; Vama Jele; Priscilla Dlamini; Wisdom Chiviya
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.